Given that patients with RA receiving MTX are co-prescribed folic acid to minimize side effects, EC were studied in the presence or absence of TNFα, with or without addition of folinic acid (FA) to extend the in vitro model (Figure 2). This evidence concerns the gene TNF and rheumatoid arthritis.